Frontier Medicines

FierceBiotech names Frontier Medicines one of its “Fierce 15” biotech companies of 2019

Frontier Medicines Announces Three Executive Hires: Chief Scientific Officer, Chief Technology Officer & Head of Degrader Technologies

Frontier Medicines launches with $67 million to develop novel medicines that drug the “undruggable” targets driving human disease

Frontier Medicines – Using Chemoproteomics to Find New Cancer Drug Targets


Leave a comment

Your email address will not be published. Required fields are marked *